TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06571812: A Clinical Study of the TSX Dental Implant System (Xpresso)

Sponsor: ZimVie · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 62 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT06571812 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06571812 Rescue Dossier →